Modification of the inflammatory mediator LRRFIP2 by the ubiquitin-like protein FAT10 inhibits its activity during cellular response to LPS

Biochemical and Biophysical Research Communications

Volumn 428, Issue 1, 2012, Pages 11-16

  Buchsbaum, Samuel ^a   Bercovich, Beatrice ^a   Ziv, Tamar ^a   Ciechanover, Aaron ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Diubiquitin; FAT10; FATylation; Inflammation; NF B; Ubiquitin D

Indexed keywords

HLA F ASSOCIATED TRANSCRIPT 10 PROTEIN; I KAPPA B; LEUCINE RICH REPEAT FLI I INTERACTING PROTEIN 2; LIPOPOLYSACCHARIDE; LULL1 PROTEIN; MEMBRANE PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN SERINE THREONINE KINASE; TOLL LIKE RECEPTOR 4; UBIQUITIN; UNCLASSIFIED DRUG;

ARTICLE; CELL FRACTIONATION; CELLULAR PARAMETERS; CELLULAR RESPONSE; CHEMICAL REACTION; COVALENT BOND; CYTOSOL; ENDOPLASMIC RETICULUM; FATYLATION; GENE TRANSLOCATION; IMMUNOPRECIPITATION; INFLAMMATION; INHIBITION KINETICS; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MODIFICATION; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; CARRIER PROTEINS; CYTOSOL; HEK293 CELLS; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; INFLAMMATION; LIPOPOLYSACCHARIDES; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; NF-KAPPA B; SUBSTRATE SPECIFICITY; TOLL-LIKE RECEPTOR 4; UBIQUITINATION; UBIQUITINS;

EID: 84868343522     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.09.110     Document Type: Article

References (23)

1. Bates E.E., Ravel O., Dieu M.C., Ho S., Guret C., Bridon J.M., Ait-Yahia S., Briere F., Caux C., Banchereau J., Lebecque S. Identification and analysis of a novel member of the ubiquitin family expressed in dendritic cells and mature B cells. Eur. J. Immunol. 1997, 27:2471-2477.
2. Lee C.G., Ren J., Cheong I.S., Ban K.H., Ooi L.L., Yong Tan S., Kan A., Nuchprayoon I., Jin R., Lee K.H., Choti M., Lee L.A. Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers. Oncogene 2003, 22:2592-2603.
3. Canaan A., Yu X., Booth C.J., Lian J., Lazar I., Gamfi S.L., Castille K., Kohya N., Nakayama Y., Liu Y.C., Eynon E., Flavell R., Weissman S.M. FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences. Mol. Cell. Biol. 2006, 26:5180-5189.
4. Lukasiak S., Schiller C., Oehlschlaeger P., Schmidtke G., Krause P., Legler D.F., Autschbach F., Schirmacher P., Breuhahn K., Groettrup M. Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon. Oncogene 2008, 27:6068-6074.
5. Lim C.B., Zhang D., Lee C.G. FAT10, a gene up-regulated in various cancers, is cell-cycle regulated. Cell Div. 2006, 1:20.
6. Liu Y.C., Pan J., Zhang C., Fan W., Collinge M., Bender J.R., Weissman S.M. A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2. Proc. Natl. Acad. Sci. USA 1999, 96:4313-4318.
7. Raasi S., Schmidtke G., de Giuli R., Groettrup M. A ubiquitin-like protein which is synergistically inducible by interferon-gamma and tumor necrosis factor-alpha. Eur. J. Immunol. 1999, 29:4030-4036.
8. Buchsbaum S., Bercovich B., Ciechanover A. FAT10 is a proteasomal degradation signal that is itself regulated by ubiquitination. Mol. Biol. Cell 2012, 23:225-232.
9. Hipp M.S., Kalveram B., Raasi S., Groettrup M., Schmidtke G. FAT10, a ubiquitin-independent signal for proteasomal degradation. Mol. Cell Biol. 2005, 25:3483-3491.
10. Raasi S., Schmidtke G., Groettrup M. The ubiquitin-like protein FAT10 forms covalent conjugates and induces apoptosis. J. Biol. Chem. 2001, 276:35334-35343.
11. Chiu Y.H., Sun Q., Chen Z.J. E1-L2 activates both ubiquitin and FAT10. Mol. Cell 2007, 27:1014-1023.
12. Gavin J.M., Chen J.J., Liao H., Rollins N., Yang X., Xu Q., Ma J., Loke H.K., Lingaraj T., Brownell J.E., Mallender W.D., Gould A.E., Amidon B.S., Dick L.R. Mechanistic studies on the activation of ubiquitin and di-ubiquitin-like protein FAT10 by the ubiquitin-like modifier activating enzyme 6 Uba6. J. Biol. Chem. 2012.
13. Hiroi Y., Rechsteiner M. Ubiquitin metabolism in HeLa cells starved of amino acids. FEBS Lett. 1992, 307:156-161.
14. Shabek N., Herman-Bachinsky Y., Ciechanover A. Ubiquitin degradation with its substrate, or as a monomer in a ubiquitination-independent mode, provides clues to proteasome regulation. Proc. Natl. Acad. Sci. USA 2009, 106:11907-11912.
15. Aichem A., Pelzer C., Lukasiak S., Kalveram B., Sheppard P.W., Rani N., Schmidtke G., Groettrup M. USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis. Nat. Commun. 2010, 1:13.
16. Li T., Santockyte R., Yu S., Shen R.F., Tekle E., Lee C.G., Yang D.C., Chock P.B. FAT10 modifies p53 and upregulates its transcriptional activity. Arch. Biochem. Biophys. 2011, 509:164-169.
17. Dai P., Jeong S.Y., Yu Y., Leng T., Wu W., Xie L., Chen X. Modulation of TLR signaling by multiple MyD88-interacting partners including leucine-rich repeat Fli-I-interacting proteins. J. Immunol. 2009, 182:3450-3460.
18. Gunawardena H.P., Huang Y., Kenjale R., Wang H., Xie L., Chen X. Unambiguous characterization of site-specific phosphorylation of leucine-rich repeat Fli-I-interacting protein 2 (LRRFIP2) in Toll-like receptor 4 (TLR4)-mediated signaling. J. Biol. Chem. 2011, 286:10897-10910.
19. Goodchild R.E., Dauer W.T. The AAA+ protein torsinA interacts with a conserved domain present in LAP1 and a novel ER protein. J. Cell Biol. 2005, 168:855-862.
20. Vander Heyden A.B., Naismith T.V., Snapp E.L., Hodzic D., Hanson P.I. LULL1 retargets TorsinA to the nuclear envelope revealing an activity that is impaired by the DYT1 dystonia mutation. Mol. Biol. Cell 2009, 20:2661-2672.
21. Naismith T.V., Dalal S., Hanson P.I. Interaction of torsinA with its major binding partners is impaired by the dystonia-associated DeltaGAG deletion. J. Biol. Chem. 2009, 284:27866-27874.
22. Jin J., Li X., Gygi S.P., Harper J.W. Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging. Nature 2007, 447:1135-1138.
23. Cohen S., Ciechanover A., Kravtsova-Ivantsiv Y., Lapid D., Lahav-Baratz S. ABIN-1 negatively regulates NF-kappaB by inhibiting processing of the p105 precursor. Biochem. Biophys. Res. Commun. 2009, 389:205-210.